SKI Market

A+| A| A-|

Indian Indices

Sensex

76,503.60 -1,677.12
( -2.15%)

Global Indices

Nasdaq

52,927.94 -148.97
(-0.28%)

Dow Jones

7,522.05 -36.38
(-0.48%)

Hang Seng

67,213.51 -1,043.45
(-1.53%)

Nikkei 225

10,469.05 -196.83
(-1.85%)

Forex

USD-INR

95.36 0.17
(0.18%)

EUR-INR

108.98 0.13
(0.12%)

GBP-INR

127.38 0.36
(0.28%)

JPY-INR

0.59 0.00
(-0.24%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Shree Ganesh Remedies Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

540737

INE414Y01015

126.9843008

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

N.A

47.18

838.23

EPS(TTM)

Face Value()

Div & Yield %

13.84

Back

Board of Remus Pharmaceuticals recommends final dividend

May 21,2026

Remus Pharmaceuticals announced that the Board of Directors of the Company at its meeting held on 20 May 2026, inter alia, have recommended the final dividend of Rs 0.5 per equity Share (i.e. 5%) , subject to the approval of the shareholders.

76,503.60 -1,677.12 ( -2.15%)

52,927.94 -148.97 (-0.28%)

7,522.05 -36.38 (-0.48%)

67,213.51 -1,043.45 (-1.53%)

10,469.05 -196.83 (-1.85%)

95.36 0.17 (0.18%)

108.98 0.13 (0.12%)

127.38 0.36 (0.28%)

0.59 0.00 (-0.24%)